Adagio Medical Details $19M Private Placement, Registers 68M Shares for Resale Amid Going Concern
ADGM sits 94% above its 52-week low of $0.625.
Summary
Adagio Medical Holdings, Inc. filed a prospectus supplement detailing the terms of its $19 million private placement, crucial for addressing its 'going concern' status, while also registering up to 67.9 million shares for resale by selling stockholders, indicating significant potential dilution.
Key Events · Financing and Capital Events · ADGM
-
Details of $19 Million Private Placement
The company finalized a private placement of 9,792,506 shares (or pre-funded warrants) and accompanying Milestone Warrants, raising $19 million in gross proceeds. This financing is critical for the company's liquidity.
-
Significant Potential Dilution from Resale Registration
The prospectus registers up to 67,963,695 shares of common stock for resale by selling stockholders, which represents over 300% of the 22,210,459 shares currently outstanding, indicating substantial potential dilution.
-
Addresses 'Going Concern' Warning
This capital raise is essential for the company, which has a 'going concern' warning and projects its existing cash and cash equivalents will only fund operations into the third quarter of 2026.
-
Offering Priced at Premium to Current Market
The combined purchase price of each share and accompanying Milestone Warrants in the 2025 PIPE was $1.9403, which is a premium compared to the current stock price of $1.21, suggesting investor confidence in the company's future.
Analysis · ADGM · Industrial Applications And Services
This 424B3 prospectus supplement provides comprehensive details of Adagio Medical Holdings, Inc.'s $19 million private placement, a critical capital infusion given the company's explicit 'going concern' warning and limited cash runway into Q3 2026. The offering, which includes common stock and various warrants, was priced at a premium for the combined unit ($1.9403 vs. current $1.21 stock price), signaling investor confidence despite the company's financial distress. However, the registration of up to 67.9 million shares for resale by selling stockholders, representing over 300% of current outstanding shares, indicates substantial potential dilution. Investors should closely monitor the company's use of these funds to advance its product pipeline and achieve regulatory milestones, as well as the impact of future share sales on market dynamics.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 40.9% of the 320 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADGM was trading at $1.21 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $26.3M. The 52-week trading range was $0.63 to $2.87. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.